Catalyst
Slingshot members are tracking this event:
Summit's (SMMT) EZUTROMID Granted Fast Track Designation By FDA for Duchenne Muscular Dystrophy
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SMMT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 26, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fast Track Designation, Fda, Ezutromid, Duchenne Muscular Dystrophy
